Cargando…

Characterization of Critical Determinants of ACE2–SARS CoV-2 RBD Interaction

Despite sequence similarity to SARS-CoV-1, SARS-CoV-2 has demonstrated greater widespread virulence and unique challenges to researchers aiming to study its pathogenicity in humans. The interaction of the viral receptor binding domain (RBD) with its main host cell receptor, angiotensin-converting en...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brown, Emily E. F., Rezaei, Reza, Jamieson, Taylor R., Dave, Jaahnavi, Martin, Nikolas T., Singaravelu, Ragunath, Crupi, Mathieu J. F., Boulton, Stephen, Tucker, Sarah, Duong, Jessie, Poutou, Joanna, Pelin, Adrian, Yasavoli-Sharahi, Hamed, Taha, Zaid, Arulanandam, Rozanne, Surendran, Abera, Ghahremani, Mina, Austin, Bradley, Matar, Chantal, Diallo, Jean-Simon, Bell, John C., Ilkow, Carolina S., Azad, Taha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956771/ https://www.ncbi.nlm.nih.gov/pubmed/33668756 http://dx.doi.org/10.3390/ijms22052268

Ejemplares similares

Implications for SARS-CoV-2 Vaccine Design: Fusion of Spike Glycoprotein Transmembrane Domain to Receptor-Binding Domain Induces Trimerization
por: Azad, Taha, et al.
Publicado: (2020)

Hippo Signaling Pathway as a Central Mediator of Receptors Tyrosine Kinases (RTKs) in Tumorigenesis
por: Azad, Taha, et al.
Publicado: (2020)

SARS-CoV-2 S1 NanoBiT: A nanoluciferase complementation-based biosensor to rapidly probe SARS-CoV-2 receptor recognition
por: Azad, Taha, et al.
Publicado: (2021)

Nanoluciferase complementation-based bioreporter reveals the importance of N-linked glycosylation of SARS-CoV-2 S for viral entry
por: Azad, Taha, et al.
Publicado: (2021)

Single-dose replicating poxvirus vector-based RBD vaccine drives robust humoral and T cell immune response against SARS-CoV-2 infection
por: Boulton, Stephen, et al.
Publicado: (2022)

A High-Throughput NanoBiT-Based Serological Assay Detects SARS-CoV-2 Seroconversion
por: Azad, Taha, et al.
Publicado: (2021)

A T cell-targeted multi-antigen vaccine generates robust cellular and humoral immunity against SARS-CoV-2 infection
por: Boulton, Stephen, et al.
Publicado: (2023)

CRISPR-mediated rapid arming of poxvirus vectors enables facile generation of the novel immunotherapeutic STINGPOX
por: Whelan, Jack T., et al.
Publicado: (2023)

Engineering Rapalog-Inducible Genetic Switches Based on Split-T7 Polymerase to Regulate Oncolytic Virus-Driven Production of Tumour-Localized IL-12 for Anti-Cancer Immunotherapy
por: Martin, Nikolas T., et al.
Publicado: (2023)

Inhibition of exchange proteins directly activated by cAMP as a strategy for broad-spectrum antiviral development
por: Boulton, Stephen, et al.
Publicado: (2023)

Syngeneic mouse model of human HER2+ metastatic breast cancer for the evaluation of trastuzumab emtansine combined with oncolytic rhabdovirus
por: Taha, Zaid, et al.
Publicado: (2023)

Identification of FDA-approved bifonazole as a SARS-CoV-2 blocking agent following a bioreporter drug screen
por: Taha, Zaid, et al.
Publicado: (2022)

Probiotics in Treatment of Viral Respiratory Infections and Neuroinflammatory Disorders
por: Shahbazi, Roghayeh, et al.
Publicado: (2020)

Synthetic virology approaches to improve the safety and efficacy of oncolytic virus therapies
por: Azad, Taha, et al.
Publicado: (2023)

Anti-Inflammatory and Immunomodulatory Properties of Fermented Plant Foods
por: Shahbazi, Roghayeh, et al.
Publicado: (2021)

Fatty acid transport protein inhibition sensitizes breast and ovarian cancers to oncolytic virus therapy via lipid modulation of the tumor microenvironment
por: Surendran, Abera, et al.
Publicado: (2023)

Luciferase-Based Biosensors in the Era of the COVID-19 Pandemic
por: Azad, Taha, et al.
Publicado: (2021)

Virally programmed extracellular vesicles sensitize cancer cells to oncolytic virus and small molecule therapy
por: Wedge, Marie-Eve, et al.
Publicado: (2022)

Vanadyl sulfate-enhanced oncolytic virus immunotherapy mediates the antitumor immune response by upregulating the secretion of pro-inflammatory cytokines and chemokines
por: Alluqmani, Nouf, et al.
Publicado: (2022)

Oncolytic virus driven T-cell-based combination immunotherapy platform for colorectal cancer
por: Crupi, Mathieu J. F., et al.
Publicado: (2022)

The Role of YAP and TAZ in Angiogenesis and Vascular Mimicry
por: Azad, Taha, et al.
Publicado: (2019)

Lentinula edodes Cultured Extract and Rouxiella badensis subsp. acadiensis (Canan SV-53) Intake Alleviates Immune Deregulation and Inflammation by Modulating Signaling Pathways and Epigenetic Mechanisms
por: Shahbazi, Roghayeh, et al.
Publicado: (2023)

Novel Probiotic Bacterium Rouxiella badensis subsp. acadiensis (Canan SV-53) Modulates Gut Immunity through Epigenetic Mechanisms
por: Shahbazi, Roghayeh, et al.
Publicado: (2023)

Extracellular Vesicles and Viruses: Two Intertwined Entities
por: Moulin, Coline, et al.
Publicado: (2023)

The strategic combination of trastuzumab emtansine with oncolytic rhabdoviruses leads to therapeutic synergy
por: Arulanandam, Rozanne, et al.
Publicado: (2020)

Lighting a Fire in the Tumor Microenvironment Using Oncolytic Immunotherapy
por: Achard, Carole, et al.
Publicado: (2018)

Alzheimer’s Disease Pathogenesis: Role of Autophagy and Mitophagy Focusing in Microglia
por: Eshraghi, Mehdi, et al.
Publicado: (2021)

Dependency of EGFR activation in vanadium-based sensitization to oncolytic virotherapy
por: Wong, Boaz, et al.
Publicado: (2022)

Stat3 and Gap Junctions in Normal and Lung Cancer Cells
por: Guy, Stephanie, et al.
Publicado: (2014)

Chemical contrast for imaging living systems: molecular vibrations drive CARS microscopy
por: Pezacki, John Paul, et al.
Publicado: (2011)

Combination of Paclitaxel and MG1 oncolytic virus as a successful strategy for breast cancer treatment
por: Bourgeois-Daigneault, Marie-Claude, et al.
Publicado: (2016)

Activity-based protein profiling of the hepatitis C virus replication in Huh-7 hepatoma cells using a non-directed active site probe
por: Singaravelu, Ragunath, et al.
Publicado: (2010)

Activated Src requires Cadherin-11, Rac, and gp130 for Stat3 activation and survival of mouse Balb/c3T3 fibroblasts
por: Adan, Hanad, et al.
Publicado: (2022)

Stat3 is a positive regulator of gap junctional intercellular communication in cultured, human lung carcinoma cells
por: Geletu, Mulu, et al.
Publicado: (2012)

Enhanced susceptibility of cancer cells to oncolytic rhabdo-virotherapy by expression of Nodamura virus protein B2 as a suppressor of RNA interference
por: Bastin, Donald, et al.
Publicado: (2018)

Predictors of RBD progression and conversion to synucleinopathies
por: de Natale, Edoardo Rosario, et al.
Publicado: (2022)

Interferon-armed RBD dimer enhances the immunogenicity of RBD for sterilizing immunity against SARS-CoV-2
por: Sun, Shiyu, et al.
Publicado: (2021)

Generalized EEG Slowing Across Phasic REM Sleep, Not Subjective RBD Severity, Predicts Neurodegeneration in Idiopathic RBD
por: Gong, Si-Yi, et al.
Publicado: (2022)

From Scourge to Cure: Tumour-Selective Viral Pathogenesis as a New Strategy against Cancer
por: Ilkow, Carolina S., et al.
Publicado: (2014)

MicroRNA-124 Regulates Fatty Acid and Triglyceride Homeostasis
por: Shaw, Tyler A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_hetjrvv36ooqcaeinramird6rm